Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_2867_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
15.09.2026
Размер:
15 Мб
Скачать
☆
384
J. M. Baratta
when rapid neurological decline leads to respiratory compromise. As with other autoimmune diseases, Guillain–Barré syndrome predominantly affects females. It is the most common paralytic neuropathy, estimated to affect 100,000 per year across the globe [4]. The syndrome can be heterogeneous and further complicated by disease variants, thereby raising the risk of misdiagnosis particularly in early stages of the illness.
This case presents a man who was evaluated for acute neurological ndings. Initial workup was most consistent with posterior circulation stroke, and manage­ment was initiated accordingly. It was not until the patient’s neurological status decompensated that Guillain–Barré syndrome became a concern. Guillain–Barré syndrome was conrmed with further neurological workup including lumbar punc­ture and electrodiagnostic studies.

Clinical Case Presentation

“A 53-year-old man presented with left-arm weakness, glossolalia, and right eyelid droop for a duration of 3 h. He had a sore throat and stuffy nose 10 days earlier. Other than having hypertension and gout, his medical history was unremarkable. None of his family members had experienced similar symptoms. On admission, his vital signs were normal, and his higher mental functions were appropriate for his age. Neurological examination showed dysarthria, right eyelid droop, left facial droop, and a left-held tongue. No nystagmus, ophthalmoplegia, ataxia, or hearing loss was noticed. His muscle strength was 4/5in the left upper limb (in both the proximal and distal muscles). There was no sensory function decit. Deep tendon reexes were present and symmetrical. The results of coordination tests and gait tests were normal, and plantar responses were normal bilaterally. The results of the rest of his physical examination were normal. The results of his brain CT examina­tion were normal. In summary, he was managed as having a posterior circulation infarct. The patient and his family did not agree to intravenous thrombolysis because of the risk of bleeding. Eight hours after he was admitted, his condition deteriorated, with quadriplegia and bilateral peripheral facial palsy. Immediately, cranial mag­netic resonance imaging (MRI) with magnetic resonance angiography was per­formed, but no abnormal manifestations were found. Cervical and thoracic spinal MRI were also performed, and the results were normal. Because of his unremark­able neuroimaging results, Guillain–Barré became the primary working diagnosis. The following day, he developed bilateral ophthalmoplegia, dysphagia, dyspnea, and numbness in all extremities, and he underwent tracheotomy to prevent a wors­ening of his acute respiratory failure. Lumbar puncture was performed, and cerebro­spinal uid (CSF) analysis showed that the protein level was 0.87 g/L (normal values: 0.25–0.47g/L), while the white blood cell count was 5×106/L (normal values: 0–8× 106/L). Anti-ganglioside antibody analysis of the serum and CSF revealed high levels of anti-GQ1b. The blots for other anti-gangliosides (anti-GM1, anti-GM2, anti-GM3, anti-GD1a, anti-GD1b, and anti-GT1b) were negative. Nerve
53 Guillain–Barré Syndrome Misdiagnosed asPosterior Circulation Stroke
conduction study (NCS) results showed that the amplitudes of the bilateral facial, median, ulnar, and right peroneal (bular) motor nerves were reduced; the occur­rence rates of the F wave in the left median nerve and ulnar nerve were reduced; the F wave was absent in the right median nerve; and the rest of the testing revealed normal results. Unfortunately, the H wave could not be detected in either leg due to the limitations of the patient’s posture. According to the NCS results, mild to mod­erate damage to multiple motor nerves was considered. The patient received intra­venous immunoglobulin (0.4kg/day) for 5 days. Three weeks after admission, at discharge, his dysphagia, dyspnea, facial paralysis, ocular movement disorder, and leg weakness had recovered almost completely, but his arms were still moderately impaired, with a power of 4/5 (in both the proximal and the distal muscles). When the patient was discharged, he no longer needed a ventilator and could breathe nor­mally. The patient had to be own home, and due to safety concerns, the patient was discharged with a tracheotomy. Fortunately, the patient recovered well without any sequelae after two years of follow-up.” [5]
Case taken verbatim from source, which is open access: “Copyright © 2021 Sun, Gao, Chi, Cao, Ning and Nan. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.”
385

Differential Diagnosis

• Stroke
• Brain tumor
• Seizure
• Conversion disorder
• Complicated migraine
• Metabolic derangement
• Vestibular dysfunction
• Polyneuropathy
What WasMisdiagnosed inThis Case andWhy?
The patient in this case was diagnosed with a posterior circulation stroke after appropriate initial workup which included general and neurological physical exam and CT imaging of the head. The results of this initial evaluation were most consis­tent with stroke. It was not until the patient subsequently declined that an alternate diagnosis of atypical Guillain–Barré syndrome became more apparent.
386
J. M. Baratta

Discussion

The heterogenous presentations Guillain–Barré syndrome and variant conditions can lead to diagnostic challenges for clinicians. While the syndrome classically presents with progressive, ascending accidity and loss of reexes, symptoms can be variable particularly early in the disease process. Numerous disease variants fur­ther complicate the diagnosis. For example, the Miller–Fisher variant often presents with prominent ophthalmoplegia in addition to limb ataxia and loss of deep tendon reexes [6]. The pharyngeal-cervical-brachial variant can be seen with progressive oropharyngeal and cervicobrachial weakness accompanied by upper extremity are­exia [7].
Diagnosis of Guillain–Barre syndrome is made with careful history-taking and examination. A history of progressive, ascending loss of strength and sensation accompanied by diminished reexes is convincing [8]. Lumbar puncture should be performed on all patients with suspected Guillain–Barre and typically demonstrates albuminocytologic dissociation dened as an elevation of CSF protein without an elevation in white blood cells [9]. Electrodiagnostic studies, including nerve con­duction study and electromyography, can be helpful for diagnosis, often showing delay of nerve transmission through an absent or reduced H response, F wave, and abnormal upper extremity sensory nerve action potential combined with a normal sural sensory nerve action potential [10].
Treatment is multipronged and frequently includes high-dose steroids, intrave­nous immunoglobulin, and plasmapheresis. Supportive care is necessary for those with nutritional and respiratory deciencies, potentially involving provision of par­enteral feeding and mechanical ventilation [11]. Mortality typically involves respi­ratory failure and is estimated at 3–10%. Symptoms typically peak at 4weeks after disease onset and gradually remit with time. At 6months after disease onset, 20% of patients are still unable to ambulate [12]. Pain, fatigue, and other functional impairments may continue for months or years.

Conclusion

Guillain–Barré syndrome is the most common paralytic neuropathy globally. While initial symptoms classically include ascending weakness and areexia, the presen­tation can be heterogeneous leading to diagnostic challenges. A thorough history and physical examination along with frequent re-evaluation are critical for patients presenting with acute neurological concerns. Appropriate diagnosis is necessary for timely administration of immunomodulating treatments to minimize disease progression.
53 Guillain–Barré Syndrome Misdiagnosed asPosterior Circulation Stroke
387

References

1. Shahrizaila N, et al. Guillain-Barré syndrome. Lancet (London, England). 2021;397(10280):1214–28. https://doi.org/10.1016/S0140- 6736(21)00517- 1.
2. Jasti AK, et al. Guillain-Barré syndrome: causes, immunopathogenic mechanisms and treatment. Expert Rev Clin Immunol. 2016;12(11):1175–89. https://doi.org/10.108
0/1744666X.2016.1193006.
3. Caress JB, etal. COVID-19-associated Guillain-Barré syndrome: the early pandemic experi­ence. Muscle Nerve. 2020;62(4):485–91. https://doi.org/10.1002/mus.27024.
4. Fujimura H.The Guillain-Barré syndrome. Handb Clin Neurol. 2013;115:383–402. https://
doi.org/10.1016/B978- 0- 444- 52902- 2.00021- 7.
5. Sun J, Gao Y, Chi L, Cao Q, Ning Z, Nan G.Case report: early-onset Guillain-Barre syndrome mimicking stroke. Front Neurol. 2021;12:525699. https://doi.org/10.3389/fneur.2021.525699.
6. Al Othman B, etal. Update: the Miller Fisher variants of Guillain-Barré syndrome. Curr Opin Ophthalmol. 2019;30(6):462–6. https://doi.org/10.1097/ICU.0000000000000611.
7. Wakerley BR, Yuki N. Pharyngeal-cervical-brachial variant of Guillain-Barre syndrome. J Neurol Neurosurg Psychiat. 2014;85(3):339–44. https://doi.org/10.1136/jnnp- 2013- 305397.
8. Florian IA, et al. To be, or not to be… Guillain-Barré Syndrome. Autoimmun Rev. 2021;20(12):102983. https://doi.org/10.1016/j.autrev.2021.102983.
9. van den Berg B, etal. Guillain-Barré syndrome: pathogenesis, diagnosis, treatment and prog­nosis. Nat Rev Neurol. 2014;10(8):469–82. https://doi.org/10.1038/nrneurol.2014.121.
10. Gordon PH, Wilbourn AJ.Early electrodiagnostic ndings in Guillain-Barré syndrome. Arch Neurol. 2001;58(6):913–7. https://doi.org/10.1001/archneur.58.6.913.
11. Liu S, et al. Immunotherapy of Guillain-Barré syndrome. Hum Vacc Immunotherapeut. 2018;14(11):2568–79. https://doi.org/10.1080/21645515.2018.1493415.
12. van Doorn PA. Diagnosis, treatment and prognosis of Guillain-Barré syndrome (Guillain­Barre). Presse medicale (Paris, France : 1983). 2013;42(6 Pt 2):e193–201. https://doi.
org/10.1016/j.lpm.2013.02.328.
Chapter 54
Stroke Misdiagnosed asBenign Positional Paroxysmal Vertigo
JohnMichaelBaratta

Introduction

Stroke is a leading cause of disability and death both in the United States and glob­ally. Efcient and accurate evaluation of a person with suspected stroke is particu­larly important given the rapid destruction of neurons, lending to the saying “time is brain.” [1] Newer interventions for stroke, including intravenous tissue-type plas­minogen activator (IV tPA) and mechanical thrombectomy, can dramatically improve mortality as well as neurological and functional outcomes.
In the United States, it is estimated that 800,000 people suffer a stroke annually, with a total cost exceeding 40 billion dollars. Stroke is classically associated with facial droop, arm or leg weakness, and speech difculties; however in many cases stroke does not present typically. There are often nonspecic symptoms such as diz­ziness or transient numbness that increase the risk of misdiagnosis. In the United States, it is estimated that there are up to 165,000 missed stroke diagnoses annually. Inability to diagnose stroke in the emergency department may lead to failure of acute intervention and secondary prevention therapy resulting in higher risk of mor­tality and morbidity. The risks of a missed stroke diagnosis are higher for younger, female, and non-White patients [2, 3].
Most frequently error occurs in posterior circulation infarcts with presenting symptoms such as nausea, headache, and dizziness. Identifying symptoms like these that are not specic but accompanied by neurologic signs such as ataxia and Horner syndrome will reduce the rate of misdiagnosis. Additional symptoms which can help
J. M. Baratta (*) Department of Physical Medicine and Rehabilitation, Medical Director of Stroke Rehabilitation, University of North Carolina School of Medicine, Chapel Hill, NC, USA e-mail: john_baratta@med.unc.edu
© The Author(s), under exclusive license to Springer Nature Switzerland AG 2023 H. Tohid et al. (eds.), The Misdiagnosis Casebook in Clinical Medicine,
https://doi.org/10.1007/978-3-031-28296-6_54
389
390
J. M. Baratta
with stroke identication include crossed motor sensory problems, oculomotor nerve palsies, and visual eld defecits [2].
Initial presentation of stroke can be variable and can include arm or leg weak­ness, facial droop, slurred speech, gait instability, confusion, and headache. Due to the complex nature of the central and peripheral nervous systems, stroke mimics are a frequent concern. Stroke mimics can vary widely and include seizure, metabolic derangement, complicated migraine, vestibular dysfunction, and polyneuropathy. A thorough review of the history, physical examination, and diagnostic studies is criti­cal to achieving the proper diagnosis and initiating appropriate, timely manage­ment. In this case, the 50-year-old patient checked himself into the emergency department for a 3-week history of frequent episodes of gait imbalance, nausea, blurred vision, and tinnitus.
Learning Objectives
By the end of this presentation, the clinician will be able to:
1. Articulate ideas about the signs and symptoms of case presentation in this
condition.
2. Discuss an alternative diagnosis of stroke.
3. Enumerate the various diagnostic techniques used in the investigation of this
condition.
4. Discuss why this condition is often misdiagnosed with presentation of its
symptoms.

Clinical Case Presentation

A 50-year-old male with a history of smoking and alcohol use presented to the emergency department with recurring episodes of gait imbalance, nausea, blurred vision, and tinnitus. Episodes had occurred for approximately 3 weeks, lasting for several seconds to minutes, and resolved spontaneously. The patient underwent thorough physical examination. A head computed tomography was done showing normal ndings. He was discharged from the emergency department with a diagno­sis of benign positional paroxysmal vertigo. Over the following weeks, his condi­tion deteriorated instead of improving, with progressive development and worsening of diplopia and dysgraphia. Repeat brain computed tomography demonstrated mul­tiple bilateral cerebellar infarctions, and he was subsequently admitted to the hospi­tal for further evaluation and management.
On hospital day 1, the patient developed left rapid phase nystagmus which pro­gressed to rapid right phase and then bilateral nystagmus. He also had left-sided dysmetria that became right-sided and then bilateral. He also expressed concerns about dysgraphia. On hospital day 3, the patient developed dysarthria and later was started on a statin and dual antiplatelet therapy containing aspirin and clopidogrel.
54 Stroke Misdiagnosed asBenign Positional Paroxysmal Vertigo
During the admission, he underwent carotid Doppler ultrasound and blood test­ing, including cholesterol, hemoglobin A1C, and autoimmunity labs, which were unrevealing. A transesophageal echocardiogram was normal, ruling out a patent foramen ovale and intracardiac thrombus. Computed tomography angiography nd­ings revealed bilateral vertebral artery (VA) occlusions. The patient underwent interventional angiography for atheromatous stenosis greater than 50% at the right V4 segment and VA ostium. Retrograde ow with total occlusion of the distal left VA segment was noted. A vascular stent was placed in the right V4 segment with 30% of residual stenosis.
After the procedure, the patient’s status improved substantially. He was noted to have substantial reductions in nystagmus and balance impairment. The patient improved to the point that he could return to walking and performing activities of daily living independently. He was discharged with dual antiplatelet therapy. After 1 year he had recovered well with minor residual effects of mild dysgraphia and slowed cognition.
[Case source: Costa, Ana et al. “A Patient With (Initially) Non-Persistent Vertigo - A Posterior Circulation Stroke Case.” Cureus vol. 14,1 e21468. 21 Jan. 2022, doi:10.7759/cureus.21468]
391

Differential Diagnosis

1. Benign paroxysmal positional vertigo
2. Brain tumor
3. Functional neurological disorder
4. Seizures
5. Migraine
What WasMisdiagnosed inThis Case andWhy?
The patient was diagnosed with a benign paroxysmal positional vertigo after initial workup which included computed tomography head which was negative for stroke. More sensitive imaging, such as magnetic resonance imaging brain, was not per­formed during the initial workup. Further diagnostic testing was completed when the patient’s symptoms worsened over the following weeks. Interventional angiog­raphy demonstrated bilateral vertebral artery stenosis which had resulted in substan­tially reduced ow and was likely the source of thromboembolic events.
392
J. M. Baratta

Discussion

Stroke is a heterogeneous disease as well as a leading cause of death and disability [4]. Depending on its etiology and location, acute stroke can present with a variety of symptoms including arm or leg weakness, facial droop, slurred speech, gait insta­bility, confusion, and headache [5]. The challenging nature of acute stroke presenta­tions and numerous stroke mimics can lead even experienced clinicians to a misdiagnosis [6].
Efcient and accurate evaluation is critical for optimal stroke management, as key acute ischemic stroke interventions, such as intravenous tissue-type plasmino­gen activator and mechanical thrombectomy, are time-limited [7]. For this reason, many medical centers have developed acute stroke management pathways to mini­mize wait times for patients with stroke-like symptoms to undergo critical compo­nents of the evaluation, such as head imaging and neurology consultation [8]. Implementation of acute stroke interventions can provide the patient a substantial benet in acute survival rates and long-term neurological sequelae [9]. Evaluation of patients with acute stroke-like symptoms should include emergent head imaging [8]. This is most often done with computed tomography as it is faster and less expensive to perform than other modalities but still sufcient to evaluate for a hem­orrhagic event. It should be noted, however, that a negative head computed tomog­raphy in the acute phase does not rule out an acute ischemic event given the poor sensitivity of this test in the acute phase of stroke [10]. In patients with unclear or uctuating symptoms, magnetic resonance imaging or contrasted imaging modali­ties may be better able to determine the source of symptoms [11, 12]. In this case, it was not until magnetic resonance imaging and angiography were performed that the correct diagnosis of vertebral artery occlusion leading to posterior circulation stroke was made.

Conclusion

Evaluation of people with stroke-like symptoms can pose diagnostic challenges due to the heterogeneous nature of presentations. Initial workup should include head imaging such as computed tomography; however it should be noted that negative initial computed tomography should not rule out acute ischemic stroke. Other diag­nostic imaging modalities, such as magnetic resonance imaging and angiography, should be considered for further evaluation of patients with an initial nega­tive workup.
54 Stroke Misdiagnosed asBenign Positional Paroxysmal Vertigo
393

References

1. Saver JL.Time is brain—quantied. Stroke. 2006;37(1):263–6.
2. Newman-Toker DE, Moy E, Valente E, Coffey R, Hines AL.Missed diagnosis of stroke in the emergency department: a cross-sectional analysis of a large population-based sample. Diagnosis (Berl). 2014;1(2):155–66. https://doi.org/10.1515/dx- 2013- 0038.
3. León Cejas L, Mazziotti J, Zinnerman A, Nofal P, Fernández Pardal M, Bonardo P, Reisin R. Misdiagnosis of acute ischemic stroke in young patients. Medicina (B Aires). 2019;79(2):90–4.
4. Costa A, etal. A patient with (initially) non-persistent vertigo- a posterior circulation stroke case. Cureus. 2022;14(1):e21468. https://doi.org/10.7759/cureus.21468.
5. Guzik A, Bushnell C.Stroke epidemiology and risk factor management. Cerebrovascular Disease Continuum (Minn). 2017;23(1):15–39. https://doi.org/10.1212/CON.0000000000000416.
6. Pare JR, Kahn JH.Basic neuroanatomy and stroke syndromes. Emerg Med Clin North Am. 2012;30(3):601–15. https://doi.org/10.1016/j.emc.2012.05.004.
7. Buck B, etal. Stroke mimics: incidence, aetiology, clinical features and treatment. Ann Med. 2021;53(1):420–36. https://doi.org/10.1080/07853890.2021.1890205.
8. Powers WJ, etal. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2019;50(12):e344–418. https://doi.org/10.1161/STR.0000000000000211
9. Herpich F, Rincon F. Management of acute ischemic stroke. Crit Care Med. 2020;48(11):1654–63. https://doi.org/10.1097/CCM.0000000000004597.
10. Hasan TF, etal. Overview of acute ischemic stroke evaluation and management. Biomedicine. 2021;9(10):1486. https://doi.org/10.3390/biomedicines9101486.
11. Smajlović D, Sinanović O.Sensitivity of the neuroimaging techniques in ischemic stroke. Med Arh. 2004;58(5):282–4.
12. Simonsen CZ, etal. Which imaging approach should be used for stroke of unknown time of onset? Stroke. 2021;52(1):373–80. https://doi.org/10.1161/STROKEAHA.120.032020.
Chapter 55
Primary Amoebic Meningoencephalitis Misdiagnosed asPyogenic Meningitis
SathishVenugopal
Learning Objectives
By the end of this presentation, the clinician will be able to:
1. Demonstrate an appropriate understanding of the condition and its causative organism.
2. Describe the conditions that present with a similar pattern as primary amoebic meningoencephalitis.
3. Articulate the knowledge of symptomatology and proper history of the patient to narrow down the diagnosis.
4. Discuss the course of disease, management techniques, and various treatment modalities to help patients recover quickly.
5. Enumerate the various diagnostic techniques from laboratory tests done to tech­niques like next-generation sequencing and polymerase chain reaction.

Introduction

This disease was rst identied in 1899 caused by a protist pathogen called Naegleria fowleri. It causes fatal infection of the central nervous system that has acute phase infection and rapid progression. This condition arises when the organ­ism, Naegleria fowleri, is accidentally introduced via nasal route. Through the crib- riform plate, amoeba enters the central nervous system and advances along the cribriform plate, following the olfactory nerve. Naegleria fowleri is a thermophile,
S. Venugopal (*) St. Martinus University Faculty of Medicine, Willemstad, Curacao e-mail: sathish.venugopal@martinus.edu
© The Author(s), under exclusive license to Springer Nature Switzerland AG 2023 H. Tohid et al. (eds.), The Misdiagnosis Casebook in Clinical Medicine,
https://doi.org/10.1007/978-3-031-28296-6_55
395